JW Pharmaceutical Deal History & Licensing Activity
JW Pharmaceutical is a life sciences. Over the past three years, JW Pharmaceutical has been involved in 1 licensing and acquisition transaction, with a primary focus on Peptides (2 deals). The company currently has 13 active clinical trials, primarily in Metabolic.
Deals (12mo)
1
Active Trials
13
Top Modality
Peptides
Focus Area
Metabolic
JW Pharmaceutical Recent Deal Activity
Licensing, acquisition, and partnership transactions involving JW Pharmaceutical in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Bofanglutide Injection | Gan & Lee Pharmaceuticals | Peptides | Phase 3 | license | Apr 2026 |
JW Pharmaceutical Pipeline Focus
Therapeutic areas and modalities where JW Pharmaceutical is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
JW Pharmaceutical Clinical Pipeline
JW Pharmaceutical has 13 active clinical trials across 3 development phases.
2
Phase 4
6
Phase 1
5
Phase 3
See How Your Asset Matches JW Pharmaceutical's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Metabolic assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Metabolic Deal Benchmarks
Market sizing, deal terms, and competitive landscape for metabolic
Cardiovascular Deal Benchmarks
Market sizing, deal terms, and competitive landscape for cardiovascular
Peptides Benchmarks
Upfront, milestone, and royalty benchmarks for peptides deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About JW Pharmaceutical Licensing & Deal Activity
JW Pharmaceutical is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, JW Pharmaceutical ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for JW Pharmaceutical include Metabolic (5 deals and trials), Solid Tumors (1 deal and trial), and Cardiovascular (1 deal and trial). In terms of modality, JW Pharmaceutical has shown particular interest in peptides.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for JW Pharmaceutical and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against JW Pharmaceutical's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.